A federal judge has temporarily blocked a Minnesota medical spa from using Eli Lilly’s Mounjaro trademark to advertise compounded drugs that contain tirzepatide.
Eli Lilly and its GLP-1 rival Novo Nordisk have been on a legal campaign to stop wellness centers and compounding pharmacies that they believe are improperly advertising…
Click here to view original post
Healthcare providers gain access to first-of-its-kind generative AI technology, leading to faster and more accurate payments LEHI, Utah, and LOUISVILLE, Ky., Jan. 13, 2025 /PRNewswire/ — Waystar (Nasdaq: WAY), a provider of leading healthcare payment […]
SALT LAKE CITY–(BUSINESS WIRE)–iVeena Delivery Systems Inc. (“iVeena”), a biopharmaceutical company with a developmental product in pediatric myopia is pleased to announce that Dr. Sarah Molokhia, Vice President of Research & Development for iVeena and […]
Monica Bertagnolli passed through the final step to become President Biden’s first Senate-confirmed NIH director in nearly two years with a 62-36 vote on Tuesday. Bertagnolli, who currently heads the NIH’s National Cancer Institute, faced […]
Copyright © 2026 Biotech Networks
